| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$434 |
Titomic Investor Day in Huntsville
|
27 Feb 2026 9:06AM |
$0.200 |
$0.270 |
risen by
35%
|
|
| Alcoa Corporation (AAI) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$3,447 |
Annual Report on Form 10-K for year ended December 31, 2025
|
27 Feb 2026 9:06AM |
$90.430 |
$89.620 |
fallen by
0.90%
|
|
| Harvey Norman Holdings Ltd (HVN) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,595 |
Results Announcement 1H26
|
27 Feb 2026 9:06AM |
$6.330 |
$4.490 |
fallen by
29.07%
|
|
HVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit before tax increased by 16.5% to $466.31 million.
- System sales revenue grew by 6.9% to $5.16 billion.
- Australian franchisee sales increased by 4.8%.
- Company-operated sales rose by 11.6%.
- Franchising operations profit before tax increased by 14.2%.
- Overseas retail segment profit before tax increased by 35.6%.
- Strong performances noted in New Zealand, Ireland, Slovenia, Croatia, Singapore, and Malaysia.
- Operating expenses reduced to 17.8% of system sales.
- Property segment profit before tax increased by 7.8%.
- Balance sheet strengthened with increased assets and conservative gearing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$434 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2026 9:06AM |
$0.200 |
$0.270 |
risen by
35%
|
|
| Harvey Norman Holdings Ltd (HVN) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,595 |
Half Yearly Report and Accounts
|
27 Feb 2026 9:06AM |
$6.330 |
$4.490 |
fallen by
29.07%
|
|
HVN - Price-sensitive ASX Announcement
Full Release
Key Points
- System sales growth of 6.9% to $5.16 billion.
- Company-operated sales revenue increased by 11.6% to $1.66 billion.
- Aggregated headline franchisee sales revenue rose by 4.8% to $3.50 billion.
- Profit Before Tax increased by 16.5% to $466.31 million.
- PBT excluding AASB 16 and property revaluations up by 20.1% to $372.79 million.
- International operations account for 25% of total PBT excluding property revaluations.
- Low net debt to equity ratio of 13.02%.
- Ample cash reserves with operating cash flows of $392.88 million.
- Interim dividend per share increased by 20.8% to 14.5 cents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$30 |
Appendix 4D and Half Year Report
|
27 Feb 2026 9:06AM |
$0.090 |
$0.062 |
fallen by
31.11%
|
|
AR9 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half-year was $6,085,350, an increase from $2,769,834 in the prior period.
- The company reported a total comprehensive loss of $7,199,095 for the period.
- Significant investments were made in intangible assets, with the total reaching $29,705,853.
- Net cash used in operating activities was $6,273,992.
- The company raised $27,962,655 through the issue of shares.
- The report includes detailed financial statements, including profit or loss, cash flows, and changes in equity.
- archTIS Limited operates in the software and services sector related to information management and security.
- The cash balance as of December 31, 2025, was $6,488,262.
- The company's directors include Dr. Miles Jakeman AM, Dr. Marcus Thompson AM, and Mr. Daniel Lai.
- The financial report was prepared in accordance with Australian Accounting Standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$14,698 |
WiseTech CEO share purchase
|
27 Feb 2026 9:05AM |
$49.000 |
$43.730 |
fallen by
10.76%
|
|
| Heavy Rare Earths Limited (HRE) ORDINARY FULLY PAID |
Materials |
$6 |
Change of Director's Interest Notice
|
27 Feb 2026 9:04AM |
$0.043 |
$0.027 |
fallen by
37.21%
|
|
| Bougainville Copper Limited (BOC) 1 KINA ORDINARY FULLY PAID |
Materials |
$255 |
Initial Director's Interest Notice - Sir Moi Avei
|
27 Feb 2026 9:04AM |
$0.870 |
$0.635 |
fallen by
27.01%
|
|
| Jupiter Mines Limited. (JMS) ORDINARY FULLY PAID |
Materials |
$511 |
Half-Year Report and Appendix 4D-31 December 2025
|
27 Feb 2026 9:04AM |
$0.300 |
$0.260 |
fallen by
13.33%
|
|
JMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit after tax increased to $16.2 million for HY2026.
- Tshipi recorded a net profit after tax of ZAR369 million.
- Total manganese ore produced during the period was 1.7 million tonnes.
- Jupiter secured a 10-year MECA 3 Agreement with Transnet.
- Tshipi achieved Level 1 Broad-Based Black Economic Empowerment status.
- Exxaro Resources Limited acquired a 50.1% interest in Tshipi.
- Revenue remained stable at $4.3 million.
- Strategic focus on logistics capacity and sustainability.
- Cash and cash equivalents at the end of the period were $11.4 million.
- Directors declared a final dividend of 0.0075 per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$434 |
Results Release
|
27 Feb 2026 9:03AM |
$0.200 |
$0.270 |
risen by
35%
|
|
| Astron Corporation Limited (ATR) ORDINARY FULLY PAID |
Materials |
$245 |
Financial Statements - half year ended 31 December 2025
|
27 Feb 2026 9:03AM |
$0.610 |
$0.580 |
fallen by
4.92%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$434 |
Annual Report to Shareholders
|
27 Feb 2026 9:03AM |
$0.200 |
$0.270 |
risen by
35%
|
|
| Nexsen Limited (NXN) ORDINARY FULLY PAID |
Health Care |
$19 |
Change in substantial holding - Nexsen
|
27 Feb 2026 9:03AM |
$0.160 |
$0.200 |
risen by
25%
|
|
| Nimy Resources Limited (NIM) ORDINARY FULLY PAID |
Materials |
$22 |
Nimy to join W.A. Critical Mineral Delegation to the U.S.
|
27 Feb 2026 9:03AM |
$0.061 |
$0.061 |
fallen by
0%
|
|
NIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Nimy Resources will join the WA Government's Critical Minerals and Energy Partnerships Trade Mission to the U.S.
- The mission is led by WA Mines and Petroleum Minister David Michael.
- Nimy aims to discuss its Mons Gallium Block 3 resource with U.S. investors, financiers, and customers.
- The purpose is to strengthen critical minerals partnerships and build on the Australia-U.S. critical minerals framework.
- The mission includes meetings in New York and Washington DC.
- Nimy is positioned to leverage the growing commercial ties with North America.
- Nimy's Mons Gallium Block 3 hosts a JORC Inferred Resource with significant gallium and rare earth oxides.
- The delegation seeks to address the gallium shortage exacerbated by China's export controls.
- A scoping study on the Mons Gallium Block 3 project is underway and expected to complete in the second quarter of 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,848 |
Ryoncil Profits Underpinning Substantial Growth Pipeline
|
27 Feb 2026 9:02AM |
$2.420 |
$2.200 |
fallen by
9.09%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful U.S. commercial launch of Ryoncil® generated significant revenue growth.
- Ryoncil® gross sales reached US$57.0 million, with revenue of US$48.7 million after adjustments.
- Net loss improved to US$40.2 million compared to US$47.9 million in the previous year.
- Ryoncil® covered by both government and commercial payers, extending to 280 million U.S. lives.
- Mesoblast aims to expand Ryoncil® indications for lifecycle extension in adults and children.
- Phase 3 trial for Ryoncil® as second-line treatment for adults with SR-aGvHD is planned.
- Positive feedback received from FDA for Ryoncil® and rexlemestrocel-L trials.
- Financial stability supported by US$125.0 million non-dilutive credit-line facility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$434 |
Appendix 4E
|
27 Feb 2026 9:01AM |
$0.200 |
$0.270 |
risen by
35%
|
|
TTT - Price-sensitive ASX Announcement
Full Release
Key Points
- Titomic Limited's Appendix 4E financial report.
- Reporting period: six months ending 31 December 2025.
- Revenue decrease by 44.1% to $5.27 million.
- Loss after tax decrease by 10.2% to $17.85 million.
- No dividends paid or declared.
- Financial year-end changed to 31 December.
- Results not directly comparable to previous period.
- Unmodified audit opinion issued.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VanEck 1-5 Year Australian Government Bond ETF (1GOV) |
Financials |
$25 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$51.320 |
$50.790 |
fallen by
1.03%
|
|
| VanEck 10+ Year Australian Government Bond ETF (XGOV) |
Financials |
$379 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$50.850 |
$49.310 |
fallen by
3.03%
|
|
| Vaneck Australian Fixed Rate Subordinated Debt ETF (FSUB) |
Financials |
$23 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$25.350 |
$24.720 |
fallen by
2.49%
|
|
| VanEck Global Listed Private Credit (AUD Hedged) ETF (LEND) |
Financials |
$228 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$15.450 |
$15.700 |
risen by
1.62%
|
|
| VanEck Australian Floating Rate ETF (FLOT) |
Financials |
$1,131 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$25.000 |
$24.910 |
fallen by
0.36%
|
|
| VanEck 1-3 Month US Treasury Bond ETF (TBIL) |
Financials |
$105 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$47.090 |
$46.510 |
fallen by
1.23%
|
|
| VanEck Australian Subordinated Debt ETF (SUBD) |
Financials |
$3,570 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$25.330 |
$25.170 |
fallen by
0.63%
|
|
| VanEck Emerging Income Opportunities Active ETF (Managed Fund) (EBND) |
Financials |
$277 |
Final Dividend/Distribution for period ending 28 Feb 2026
|
27 Feb 2026 9:01AM |
$10.980 |
$10.670 |
fallen by
2.82%
|
|
Call 1300 880 160
Start a chat
Schedule a call
